Literature DB >> 21372117

Critical appraisal of animal models of multiple sclerosis.

David Baker1, Wouter Gerritsen, Jon Rundle, Sandra Amor.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a spectrum of neurological disorders in laboratory animals that is used to model multiple sclerosis (MS). However, few agents have translated from efficacy in EAE to the treatment of human disease. Although this may reflect species differences in pathological disease mechanisms, importantly it may also relate to the practice of how drugs and models are currently used. This often bears very little resemblance to the clinical scenarios where treatments are investigated, such that lack of appreciation of the biology of disease may doom drugs to failure. The use of EAE is critically appraised with the aim of provoking thought, improving laboratory practise and aiding researchers and reviewers to address quality issues when undertaking, reporting and interpreting animal studies related to MS research. This is important as many researchers using EAE could and should do more to improve the quality of the studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372117     DOI: 10.1177/1352458511398885

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  35 in total

Review 1.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

Review 2.  Animal extremists' threats to neurologic research continue: Neuroreality II.

Authors:  David Q Beversdorf; Raymond P Roos; W Allen Hauser; Vanda A Lennon; Mark F Mehler
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

3.  A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Authors:  Xiao-Lu Yuan; Yi-Peng Zhao; Jie Huang; Jun-Chen Liu; Wen-Qian Mao; Jun Yin; Bi-Wen Peng; Wan-Hong Liu; Song Han; Xiao-Hua He
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

4.  Live imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair.

Authors:  Ferdinand Kaya; Abdelkrim Mannioui; Albert Chesneau; Sowmya Sekizar; Emmanuelle Maillard; Chantal Ballagny; Ludivine Houel-Renault; David Dupasquier; Odile Bronchain; Isabelle Holtzmann; Anne Desmazieres; Jean-Léon Thomas; Barbara A Demeneix; Peter J Brophy; Bernard Zalc; Andre Mazabraud
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

Review 5.  Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?

Authors:  U-C Meier; G Giovannoni; J S Tzartos; G Khan
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 6.  Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.

Authors:  Gareth Pryce; Dieter R Riddall; David L Selwood; Gavin Giovannoni; David Baker
Journal:  J Neuroimmune Pharmacol       Date:  2014-12-24       Impact factor: 4.147

Review 7.  Contraceptive use among women with multiple sclerosis: a systematic review.

Authors:  Lauren B Zapata; Titilope Oduyebo; Maura K Whiteman; Maria K Houtchens; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2016-07-21       Impact factor: 3.375

8.  Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment.

Authors:  Youmin Kang; Yuhan Sun; Jingyao Zhang; Wenjuan Gao; Jingjing Kang; Yongqiang Wang; Bin Wang; Guoliang Xia
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 9.  Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?

Authors:  Jorge Correale; Mauricio F Farez
Journal:  Front Cell Infect Microbiol       Date:  2012-08-24       Impact factor: 5.293

10.  A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.

Authors:  Michaela Nygårdas; Henrik Paavilainen; Nadine Müther; Claus-Henning Nagel; Matias Röyttä; Beate Sodeik; Veijo Hukkanen
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.